Informed Choices and Early Dementia Risk Disclosure in Home‐Based Assessments in the PREDICTOM Study: A Public Involvement Approach

Abstract

Background: The rapid progress in detecting dementia risk through emerging digital biomarkers and biofluid markers, alongside the development of disease modifying treatments (DMTs), underscores the importance of this evolving field.